image

WDB contributes to the
future development of the
Medical & Pharmaceutical Industry.

As a contract research organization (CRO), we support pharmaceutical product
development, clinical research and trial based in the U.S.

Press Release
September 6, 2018
DZS Clinical Services Acquired by WDB Holdings Co., Ltd., to Strengthen CRO BusinessPDF
August 31, 2018
Announcement on Acquisition of 100% shares by a subsidiary in the USPDF

What We Do

WDB Group is providing our CRO services as DZS Clinical Services in the U.S.

Medical Call Center

24/7 Call Center covering global languages.

Pharmacovigilance

End-to-end Case Processing, Management, Reports.

EU Pharmacovigilance
& QPPV Services

Providing compliance to the drug safety regulations.

Regulatory Affairs Services

Dossier development, SmPC/PL development, eCTD publishing, Reviews, Variations, and maintenance.

Regulatory Affairs for PMDA

Pharmaceuticals, medical devices registration in Japan.

Clinical Data Management & Biostatistics

End-to-end Data Capture, Analysis, Management, Reports.

Who we are

As a full-service Contract Research Organization (CRO), we are a global provider of clinical research and R&D services to the biopharmaceutical and medical device industries. Our capabilities include providing comprehensive services to U.S. companies with coverage additionally in Europe and Japan.

Global expansion

As we embark on expanding our business worldwide, our steadfast mission remains the same: to guarantee top-quality-services for pharmaceutical companies. While we are enjoying the success of WDB Group in Japan, we believe establishing corporate locations in the United States, Finland, India, and Singapore, will give us the ability to provide even greater flexibility, availability and affordability to more businesses and institutions worldwide.

We sincerely appreciate your interest in WDB Group and thank you for your support.

President & CEO
Norifumi Ninokata

Company Overview

WDB Medical Data, Inc.

https://www.wdb-md.com
President & CEO: Nino, Norifumi Ninokata
Head office: 707 State Road, Suite 222, Princeton, NJ 08540
Phone #: +1-609-212-2111
Email: info@dzs.com
Business: Clinical trials
Data management
Biostatistics
Regulatory affairs
Medical Call Center
Pharmacovigilance
Shareholder: WDB Holdings Co., Ltd. (100%)

WDB Holdings Co., Ltd.

https://www.wdbhd.co.jp/eng/
Incorporation: July 1985
President & CEO: Toshimitsu Nakano
Stock listing: Tokyo Stock Exchange (Code 2475)
Head office: Tokyo / Hyogo, Japan
Number of Group Companies: 19
Number of Employees: 920
Group Business at a Glance
URL: https://www.wdbhd.co.jp/eng/about/group.html

OUR HISTORY

Since our start in 1985, WDB Group has been providing human resource services primarily for research and development in the pharmaceutical sector.

Historical Timeline

WDB is Founded

Established Work Data Bank Co. Ltd. (predecessor of the current WDB Holdings Co., Ltd.) at 68 Honmachi, Himeji-shi with ¥1 million paid in capital. Started the first administrative support service in Himeji.

1985

Staffing and Placement Services Developed

WDB develops temporary & permanent staffing services for HR

1980s
-
1990s

Business Expansion (established group companies)

2006 Listed on JASDAQ
2008 Listed on the Second Section of Tokyo Stock Exchange

2000+

Mergers & Acquisitions, Overseas, CRO Established

Click detailed timeline for more

2010+
July 1985
Established Work Data Bank Co. Ltd. (Predecessor of the current WDB Holdings Co., Ltd.) at 68 Honmachi, Himeji-shi with ¥1 million paid-in capital.
Started the first administrative support service in Himeji.
July 1986
Worker Dispatching Undertakings Act comes into force.
June 1987
Capital increased to ¥8 million.
December 1989
Capital increased to ¥10 million.
May 1990
Capital increased to ¥15 million.
September
Head Office moved to the Sompo Japan Himeji Bldg., 2-1 Nounen-cho, Himeji-shi.
April 1991
Entered into the placement business (business managers).
June 1992
Capital increased to ¥20 million.
June 1993
Capital increased to ¥40 million.
July 1996
Capital increased to ¥80 million.
December 1999
Established Task Management Co., Ltd.
February 2001
Established Tedis Co., Ltd. (WDB Tedis Co., Ltd.)
September
Acquired Privacy Mark certification.
October
Acquired ISO9001 certification.
December
Established Research Network Co., Ltd. (Now WDB Systems Co., Ltd.)
April 2002
Opened a representative office in Shanghai (closed in February 2007)
November
Changed the company name from Work Data Bank Co., Ltd. to WDB Co., Ltd. Established Envalue Co., Ltd.
September 2003
Purchased the rights to operate branches of Human West Co., Ltd. in Okayama, Hiroshima, Takamatsu and Tokushima.
October
Task Management is made a wholly owned subsidiary through a share exchange.
Capital increased to ¥100 million.
Business tie-up with WODB.
January 2004
Established WDB EUREKA Co., Ltd.
Head Office moved to Nippon Building, 2-6-2 Otemachi, Chiyoda-ku, Tokyo.
Established Group headquarters in the Himeji Parashio 2 Building, 100 Minamiekimae-cho, Himeji-shi, Hyogo.
April
Opened the Second Stage Center (Now Science Career Agency Co.,Ltd.)
October
Capital increased to ¥200 million.
Established Mada Mada Geneki Co., Ltd. (Now Science Career Agency Co.,Ltd.)
March 2005
Genomic Brain is made a wholly-owned subsidiary through share acquisition.
May
Established RKJ Co., Ltd.
Established WDB Research and Analysis Co., Ltd.
Established WDB Doctors and Pharmacists Co., Ltd.
November
Established the Kobe Basic Research Laboratory.
February 2006
Acquired ISMS certification.
March
Capital increased to ¥404 million.
Listed on JASDAQ.
(Delisted upon being listed on the Second Section of the Tokyo Stock Exchange in May, 2008)
Acquired BS7799 certification (transitioned to ISO27001 in April 2007)
May
Established the Chuo Research Institute.
Head Office moved to the Yusen Building, 2-3-2 Marunouchi, Chiyoda-ku, Tokyo.
Group Head Office moved to Nippon Building, 2-6-2 Otemachi, Chiyoda-ku, Tokyo.
July 2007
M&A of Genomic Brain Co., Ltd. and WDB Research and Analysis Co., Ltd.
March 2008
Listed on the Second Section of the Tokyo Stock Exchange.
Capital increased to ¥480 million.
October
Kilo Technology Research Laboratory Co., Ltd. (Now WDB Functional Chemistry Co., Ltd.) is made a wholly-owned subsidiary through share acquisition.
February 2009
Established Environmental and Biological Research Institute (Now WDB Environmental & Biological Research Institute Co., Ltd.)
September
Group Head Office moved to the Yusen Building, 2-3-2 Marunouchi, Chiyoda-ku, Tokyo.
April 2010
M&A of WDB Tedis Co., Ltd., RKJ Co., Ltd. and WDB Doctors and Pharmacists Co., Ltd.
Established WDB Medical Co., Ltd.
Established Business Succession Partners Co., Ltd. (Now WDB Business Succession Partners Co., Ltd.).
June
Capital increased to ¥800 million.
October
Incorporated Environmental & Biological Research Institute and established WDB Environmental & Biological Research Institute Co., Ltd.
April 2011
ICO Co., Ltd. (Now WDB ICO Co., Ltd.) made a wholly-owned subsidiary through share acquisition.
May
Established the Tokyo Central Training Center.
June
Established Postdoc Style Co., Ltd.
Established WDB Doppo Co., Ltd.
August
Established WDB Singapore Pte. Ltd.
November
Due to the transition in structure to a holding company, the company name was changed from WDB Co., Ltd. to WDB Holdings Co., Ltd.
Due to the incorporation-type company split, WDB Co., Ltd. was established with a capital of ¥300 million, with WDB Co., Ltd. inheriting the human resource services from WDB Holdings Co., Ltd.
January 2012
Completed and moved into Head Office at 79 Toyozawa-cho, Himeji-shi, Hyogo.
April
Established WDB University Co., Ltd.
November
ICO Co., Ltd. acquires and merges with WDB Medical Co., Ltd.
Company name changed to WDB ICO Co., Ltd.
February 2013
Established Shonan Training Center.
March
Densuke Systems LLC (Now DENSUKE SYSTEMS Co., Ltd.) made a wholly-owned subsidiary through share acquisition.
June
Capital increased to ¥1 billion.
December
Listed on the First Section of the Tokyo Stock Exchange.
April 2014
Kaken Geneqs Co., Ltd. made a wholly-owned subsidiary through share acquisition.
May 2015
Established WDB Silicon Valley, Inc.
August
Established WDB Medical Data, Inc.
February 2016
Established WDB India Pvt. Ltd.
April
Established WDB Chemical Laboratory Co., Ltd.

The environment of research and development is changing rapidly, and WDB Group has continued to evolve to meet client’s needs. Of those working in the science profession, one in three originate from the WDB Group in Japan.

WDB Medical Data takes full advantage of the WDB Group’s know-how and assets utilizing a method that can only be provided by WDB Medical Data.

WDB Group has an agreement with 98% of the pharmaceutical companies (local and global) in Japan. A long-standing, trustworthy relationship has been built within the research and development and manufacturing sectors with analytical work having the greatest number of customers.

Since its inception in 1984, now WDB ICO, CRO in Japan, offers a medical-based translation and regulatory application-related material creation services to pharmaceutical organizations with more.

WDB CRO Business History

How we started with one of the top 10 Global Pharma Companies in Japan

WDB Group Advantage

WDB’s equation for success and rapid growth : Simplify, Standardize, Systemize and Run

Simplify and Standardize:

WDB created a “Standardized Business Procedure” by simplifying tasks with highly skilled workers who follow a detailed work flow. Ultimately, WDB is capable of providing high quality, efficient services at a low cost. Due to this effective business procedure, WDB has been about to expand dramatically.

Systemize:

In 1985, WDB began offering HR clerical services. In 1997, WDB expanded to offer HR services for Research and Development. These HR services for R&D positions were able to be handled by staff without any previous R&D background or knowledge. WDB made it possible for inexperienced workers who had just graduated college or part-timers without the necessary skills or experience to learn and adapt quickly due to the systematic approach and methods developed. This approach allows us to work with 98% of the pharmaceutical companies in Japan and to be #1 in R&D HR services in Japan. In 2008, WDB introduced temporary staffing services to Global Pharmaceutical Company to assist on Phamacovigilance work. We continue to provide ongoing services to Global Pharmaceutical today.

Run:

Our standardized business procedure allows us to run efficiently, to train inexperienced workers effectively and offer considerable savings to our clients. Our first successful challenge was HR for R&D positions. Our second successful challenge was CRO services in Japan. And now, our third challenge is to offer CRO services in the USA.

Contact Us

Let’s get the conversation started. Fill out the contact form below .
We will contact you promptly to answer all your questions.

Name *:

Company *:

Email *:

Phone *:

Address :

Choose Country *:

Type of Service *:

Comment/Questions (this would be a box):